Dallah Healthcare Company (4004.SR) — Cash flow
Operating, investing, and financing cash flow for Dallah Healthcare Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 538↑10.9% | 485↑21.2% | 400↑21.6% | 329↑12.8% | 292 | |
| Depreciation & Amortization | 225↑59.9% | 140↑11.8% | 126↑9.9% | 114↓0.7% | 115 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -349↓496.0% | -59↓36.1% | -43↑63.4% | -117↑8.5% | -128 | |
| Accounts Receivable | -267↓231.0% | -81↓5.5% | -76↓31.8% | -58↑40.1% | -97 | |
| Inventory | -68↓98.3% | -34↓212.8% | 30↑178.7% | -39↑25.9% | -52 | |
| Accounts Payable | -17↓130.2% | 55↑710.1% | 7↓73.7% | 26↓11.3% | 29 | |
| Other Working Capital | 3↑134.4% | 1↑129.2% | -4↑91.7% | -47↓438.6% | -9 | |
| Other Non-Cash Items | -28↓125.5% | 111↓22.2% | 143↑22.9% | 116↑40.0% | 83 | |
| Net Cash from Operating Activities | 386↓43.1% | 678↑8.4% | 626↑41.5% | 442↑22.3% | 362 | |
| Operating Cash Flow | 386↓43.1% | 678↑8.4% | 626↑41.5% | 442↑22.3% | 362 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -470↓29.1% | -364↓23.5% | -295↓68.3% | -175↓51.3% | -116 | |
| Capital Expenditure | -465↓27.4% | -365↓23.1% | -297↓69.5% | -175↓51.3% | -116 | |
| Acquisitions | -748 | 0.00 | 0.00↑100.0% | -56↓157.5% | -22 | |
| Purchases of Investments | -9 | 0.00 | 0.00↑100.0% | -0.28↑99.9% | -292 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.07 | |
| Other Investing Activities | 0.00↓100.0% | 6↑692.0% | 0.82↓85.4% | 6↑35.9% | 4 | |
| Net Cash from Investing Activities | -1,227↓243.5% | -357↓21.6% | -294↓30.0% | -226↑46.9% | -425 | |
| Financing Activities | ||||||
| Net Debt Issuance | 1,163↑53465.2% | 2↑103.4% | -63↓192.9% | 68↓80.8% | 353 | |
| Long-Term Net Debt Issuance | 0.00↓100.0% | 2↑105.4% | -40↓159.7% | 68↓80.8% | 353 | |
| Short-Term Net Debt Issuance | 1,163 | 0.00↑100.0% | -23 | 0.00 | 0.00 | |
| Net Stock Issuance | -14↑77.6% | -60 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | -14↑77.6% | -60 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | -14↑77.6% | -60 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -202↓0.6% | -201↓37.3% | -147↑18.6% | -180↓10.8% | -163 | |
| Common Dividends Paid | -202↓0.6% | -201↓37.3% | -147↑18.6% | -180↓10.8% | -163 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -62↑52.2% | -131↓4.3% | -125↓68.9% | -74↓51.7% | -49 | |
| Net Cash from Financing Activities | 885↑326.9% | -390↓16.5% | -335↓79.6% | -186↓232.0% | 141 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | 44↑164.1% | -69↓2515.8% | -3↓108.8% | 30↓61.4% | 77 | |
| Cash at Beginning of Period | 166↓29.3% | 235↓1.1% | 238↑14.4% | 208↑59.3% | 131 | |
| Cash at End of Period | 211↑26.6% | 166↓29.3% | 235↓1.1% | 238↑14.4% | 208 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | -79↓125.4% | 313↓4.9% | 329↑23.2% | 267↑8.7% | 246 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.